Madrigal Pharmaceuticals Statistics
NASDAQ: MDGLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
379.10-17.64 (-4.45%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Madrigal Pharmaceuticals by the numbers
Madrigal Pharmaceuticals has a market capitalization of $8.81 billion based on 23.23M shares outstanding. With trailing EPS of $-5.85, Madrigal Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 18.0% below its 50-day average and 23.3% below its 200-day average.
Average daily trading volume is 370.07K shares, or about $140.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MDGL valuation vs. peer median
| Metric | MDGL | Peer median | Difference |
|---|---|---|---|
| Market cap | $8.81B | $7.94B | +11% |
| Forward P/E | 36.5 | 39.6 | -8% |
| Avg. volume | 370.07K | 1.18M | -69% |
Peer median across 8 companies: SYRE, PRAX, TGTX, SMMT, PTGX, RYTM, ALKS, KNSA.
Valuation
- Market cap
- $8.81B
- Forward P/E
- 36.52
- Price / sales (latest FY)
- 9.19
- EPS (TTM)
- $-5.85
- Shares outstanding
- 23.23M
Price and trading
- Previous close
- 396.74
- Open
- 396.21
- Day range
- 377.91 – 399.43
- 52-week range
- 353.54 – 615.00
- 52-week change
- -30.82%
- 50-day moving average
- 462.33
- 200-day moving average
- 494.08
- Beta
- —
- Volume
- 327.83K
- Average volume
- 370.07K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 8.81B
- Forward Pe
- 36.52
- Eps
- -5.85
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 615.00
- Week52 Low
- 353.54
- Avg Volume
- 370.07K
- Shares Outstanding
- 23.23M
- Ma50
- 462.33
- Ma200
- 494.08
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -38.36%
- Pct From52w Low
- 7.23%